Is stage 1 cancer curable 100%
stage 1 cancer cure rates survival statistics by type 2024
| Cancer Type | Localized 5-Year Survival |
|---|---|
| Prostate cancer | ~100% |
| Thyroid cancer | ~99.9% |
| Melanoma (skin) | ~99.6% |
| Breast cancer | ~99.3% |
| Testicular cancer | ~99.2% |
| Uterine cancer | ~94.9% |
| Kidney cancer | ~92.9% |
| Cervical cancer | ~91.2% |
| Colon cancer | ~90.9% |
| Lung cancer (Stage I) | ~67% |
| Pancreatic cancer (localized) | ~44% |
How many patients get cure from cancer stage 4
stage 4 cancer cure rate survival statistics by type 2024 2025
stage 4 cancer patients who achieve complete remission long term cure immunotherapy 2025
| Cancer Type | Stage 4 (Distant) 5-Year Survival |
|---|---|
| Prostate cancer | ~38% |
| Breast cancer | ~33% |
| Thyroid cancer | ~55% |
| Testicular cancer | ~73% |
| Kidney cancer | ~16% |
| Colorectal cancer | ~13-15% |
| Lung cancer | ~6-8% |
| Pancreatic cancer | ~3-4% |
| Glioblastoma (brain) | ~6% |
| Melanoma (with immunotherapy) | ~52% at 5 years (new data) |
| Scenario | Realistic Outlook |
|---|---|
| Testicular cancer, Stage 4 | ~70-75% long-term cure |
| Hodgkin lymphoma, Stage 4 | Possible cure in ~50-65% |
| Melanoma with immunotherapy | ~20-30% durable long-term remission |
| Most solid tumors (lung, colon, pancreas) | Cure is rare; goal is disease control |
| Overall stage 4, all cancers | True cure in roughly 5-10% or less |
Is it is viral
can cancer spread from person to person contagious transmission 2024
| Virus | Cancer It Can Lead To |
|---|---|
| HPV (Human Papillomavirus) | Cervical, throat, anal cancers |
| Hepatitis B & C | Liver cancer |
| HIV | Kaposi's sarcoma, lymphoma |
| EBV (Epstein-Barr Virus) | Burkitt's lymphoma, some stomach cancers |
| HTLV-1 | Adult T-cell leukemia |
Stomach camcer
stomach gastric cancer symptoms causes treatment survival 2025
| Factor | Details |
|---|---|
| Chronic atrophic gastritis | Stomach lining thins and loses function over time |
| Diet | High salt, smoked/pickled foods, processed meats; low fruits and vegetables |
| Smoking | Roughly doubles the risk |
| Alcohol | Increases risk with heavy use |
| Family history | First-degree relatives with stomach cancer |
| Blood type A | Slightly higher risk (reason unclear) |
| Obesity | Particularly for cancers near the stomach-esophagus junction |
| Prior stomach surgery | Bile reflux can promote cancer |
| Autoimmune gastritis | Increases risk |
| Genetic syndromes | CDH1 mutation (hereditary diffuse gastric cancer), Lynch syndrome, FAP |
| Stage | Description | 5-Year Survival |
|---|---|---|
| Stage 1 | Confined to stomach wall, no/minimal node spread | ~60-70% |
| Stage 2 | Deeper wall invasion or limited lymph node spread | ~35-45% |
| Stage 3 | Extensive wall invasion and/or multiple lymph nodes | ~18-25% |
| Stage 4 | Spread to distant organs (liver, lungs, peritoneum) | ~5-6% |
| Overall (all stages) | ~20% survive 5 years or more (UK/Cancer Research UK data) |